Personalizing Health
search
Home
Corporate
About Us
How we got here
What we do
Directors & Management
Directors
Senior Management
Company Information
Reports
Announcements
Media & Investor Information
Shareholder Information
Corporate Governance
Shareholder Meetings & Notice
Licensing
Introduction
List of Licensees
Research & IP
RareCellect
ImmunAid
Nematode Project
Patent Portfolio
Medical
Overview
Breast & Ovarian Cancer
Bowel & Uterine Cancer
Neurogenetics
Epilepsy
Forensics
Overview
Presumptive & Confirmatory Testing
Individual DNA Profiling
Species Identification
Animal Forensic Testing
Paternity
Legal - Paternity
Non Legal - Paternity
Legal Practitioners
Antenatal
Deceased Estate
DNA In A Day
Sibship
Twins
Y – Chromosome
DNA Profiling
Grandparent
Immigration
Personal
Overview
Sports Performance
Ancestry
Animals
DNA Testing
BITSA
Animal Forensics
Plants
Genomic Services
Xpress Sequencing
About Us
How we got here
What we do
Directors & Management
Directors
Senior Management
Company Information
Reports
Announcements
Media & Investor Information
Shareholder Information
Corporate Governance
Shareholder Meetings & List
Licensing
Introduction
List of Licensees
Research & IP
RareCellect
ImmunAid
Nematode Project
Patent Portfolio
Announcements
Launch of BREVAGen test in US
19 June 2011
Launch of BREVAGen test in US
SERL substantial shareholder notice - 6 June 2011
06 June 2011
SERL substantial shareholder notice - 6 June 2011
US Investor Presentation - June 2011
06 June 2011
US Investor Presentation - June 2011
GTG GENE processes first BREVAGen sample
30 May 2011
GTG GENE processes first BREVAGen sample
Appendix 3B - 26 May 2011
26 May 2011
Appendix 3B - 26 May 2011
Previous Announcements
Filing Of Further Patent Infringement Suit
Genetic Technologies secures CLIA certification
Collaboration with Global Pharmaceutical Company
GTG Settlement with ViennaLab
GTG Conclusion of First Assertion 13Apr2011
<<
Start
<
Prev
1
2
3
4
5
6
7
8
9
10
Next
>
End
>>
Page 6 of 27
Announcements
Passing of Dr. Malcolm Simons
ASX Quarterly Reports - 31 December 2011
ASX share price query and response - 27 January 2012
Latest News
Biotech Daily - The Year in Review - CEO Of The Year Dr Paul MacLeman
GTG Appoints Biotech Doyen Chairman
Ladenburg Thalmann Initiates Research Coverage.
Share Price